Currently Recruiting

Current clinical trials

Therapeutic Area

Ankylosing Spondylitis
(Reference No: M098)

Eligibility Criteria

Males and Females aged 18+ years, who have been diagnosed with ankylosing spondylitis and have had inadequate treatment responses to 2 or more nonsteroidal anti-inflammatory drugs (NSAIDs) and who have not previously taken biologic disease-modifying antirheumatic drugs (bDMARDs).

Trial Details

Approx. 19 clinic visits over 2 years.

There is no cost to participate and travel expenses will be reimbursed for each clinic visit attended.

Status

Therapeutic Area

Eligibility Criteria

Males and Females aged 18+ years, who have been diagnosed with rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, ulcerative colitis or hidradenitis suppurativa and are currently taking Humira (adalimumab).